To clarify the visual cues contributing to skin moisture and dryness, a research team conducted several psychophysical ...

The FDA has approved a first-of-its-kind treatment for dry age-related macular degeneration (AMD), a leading cause of blindness in adults over 55.

Citi has initiated coverage of EyePoint (EYPT) with a buy rating, stating it sees the company's drug Duravyu as well-positioned to compete in the wAMD market. Read more here.

Rates of nearsightedness, or myopia, are skyrocketing in kids—and scientists say it has to do with how little time they’re ...

SolidddVision smart glasses aim to restore vision for people living with macular degeneration, a condition that affects ...

Toll-like receptors (TLRs) are vital components of the immune system, acting as sentinels that detect and respond to ...

Want to improve your health and fitness in 2025? The good news is you don’t need a drastic lifestyle overhaul to make a difference. Small but impactful changes can significantly improve your wellbeing ...

Reducing the risk of eye diseases involves a combination of lifestyle changes, protective measures and regular eye care ...

A new eye drop therapy offers a non-invasive alternative for treating dry age-related macular degeneration. Massively ...

Age related macular degeneration (AMD) is the leading cause of vision loss in individuals over 65, characterized by abnormal ...

Tonabersat is under clinical development by Inflammx Therapeutics and currently in Phase II for Dry (Atrophic) Macular Degeneration. According to GlobalData, Phase II drugs for Dry (Atrophic) Macular ...

EB-203 is under clinical development by Eye Bio Korea and currently in Phase II for Wet (Neovascular / Exudative) Macular Degeneration. According to GlobalData, Phase II drugs for Wet (Neovascular / ...